Shanghai-based VC managing $5B in dual-currency funds, formerly known as Morningside Venture Capital before 2020 rebrand. Invests across TMT, clean tech, and biotech in China with 11 unicorns, 30 IPOs, and 24 acquisitions in portfolio.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.